Status:
RECRUITING
The Correlation Between Microbiome of Esophageal Cancer Patients and Post Esophagectomy Anastomotic Leaks
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Esophageal Tumors
Eligibility:
All Genders
18-85 years
Brief Summary
Esophageal cancer continues to be one of the most challenging topics and the subjects of numerous studies. Surgery is the mainstay for curative treatment and the need to improve all aspects of periope...
Eligibility Criteria
Inclusion
- Cancer patients who have a surgery sample at Rambam Pathology Department
- Given written informed consent to Rambam BioBank or Midgam for collection, storage, collection of information and use for future research
- Patients with non-metastatic esophageal cancer (mid/Siewert 1/Siewert 2) who developed esophageal leak
- Patients with non-metastatic esophageal cancer (mid/Siewert 1/Siewert 2) who had no post-op complication.
Exclusion
- • Patients who had complete response are excluded due to lack of tumoral tissue in the specimen for analysis
Key Trial Info
Start Date :
January 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06136845
Start Date
January 13 2020
End Date
December 31 2027
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel, 3109601